Evidence map›Paper›PMID 38031142›Full record

ArticleMicrobiome2023

Integrating compositional and functional content to describe vaginal microbiomes in health and disease.

Johanna B Holm, Michael T France, Pawel Gajer, Bing Ma, Rebecca M Brotman, Michelle Shardell, Larry Forney, Jacques Ravel

Erratum issuedOpen access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Microbiome, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Progress in interventions for vaginal microecology.Frontiers in cellular and infection microbiology · 2026
    Review
  11. Article
  12. mSystems · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. iScience · 2025
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Johanna B HolmInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Michael T FranceInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Pawel GajerInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Bing MaInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Rebecca M BrotmanInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Michelle ShardellInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Larry ForneyDepartment of Biological Sciences, University of Idaho, Moscow, ID, USA.
Jacques RavelInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA. jravel@som.umaryland.edu.
University of Maryland, Baltimore · USUniversity of Idaho · US

Funding

Serologic Biomarkers of Human Sexually Transmitted Infection and DiseaseU19AI084044 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI RAVEL, JACQUES · 2009 to 2018
$22.8M
The Effects of Sex Hormones on Chlamydia InfectionU19AI158930 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BAVOIL, PATRIK M, GLEGHORN, JASON PAUL · 2021 to 2025
$7.7M
Longitudinal Study of the Vaginal Microbiome Prior To Incident STIR01AI116799 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BROTMAN, REBECCA M. · 2015 to 2019
$3.5M
Methods to Test the Role of Age-related Lifestyle and Vaginal Microenvironment Changes and the Prevention, Treatment, and Progression of Genitourinary Syndrome of MenopauseR01AG069915 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI REBECCA M. BROTMAN, Michelle Denise Shardell · 2021 to 2026
$3.1M
Elucidating causes of vaginal symptoms using a multi-omics approach - Admin. SupplementR01NR015495 · NINR · UNIVERSITY OF MARYLAND BALTIMORE · PI FORNEY, LARRY J, RAVEL, JACQUES · 2016 to 2020
$2.6M
The Microbial Ecology of Bacterial Vaginosis: A Fine Scale Resolution MetagenomicUH2AI083264 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI RAVEL, JACQUES · 2009 to 2011
$1.9M
Integrating multi-omics data: Modeling biomarkers and mechanisms to reduce bacterial vaginosis recurrenceK01AI163413 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HOLM, JOHANNA B. · 2021 to 2025
$464k
Host-Microbe Interactions and Incident InfectionF32AI136400 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HOLM, JOHANNA B. · 2018 to 2020
$192k
NIAID NIH HHS F32 AI136400NIAID NIH HHS K01 AI163413NIAID NIH HHS R01 AI116799NIAID NIH HHS U19 AI084044NIAID NIH HHS U19 AI158930NIAID NIH HHS UH2 AI083264NIA NIH HHS R01 AG069915NINR NIH HHS R01 NR015495NINR NIH HHS R01-NR015495
6 · The paper itself

Abstract

backgroundA Lactobacillus-dominated vaginal microbiome provides the first line of defense against adverse genital tract health outcomes. However, there is limited understanding of the mechanisms by which the vaginal microbiome modulates protection, as prior work mostly described its composition through morphologic assessment and marker gene sequencing methods that do not capture functional information. To address this gap, we developed metagenomic community state types (mgCSTs) which use metagenomic sequences to describe and define vaginal microbiomes based on both composition and functional potential.

resultsMgCSTs are categories of microbiomes classified using taxonomy and the functional potential encoded in their metagenomes. MgCSTs reflect unique combinations of metagenomic subspecies (mgSs), which are assemblages of bacterial strains of the same species, within a microbiome. We demonstrate that mgCSTs are associated with demographics such as age and race, as well as vaginal pH and Gram stain assessment of vaginal smears. Importantly, these associations varied between mgCSTs predominated by the same bacterial species. A subset of mgCSTs, including three of the six predominated by Gardnerella vaginalis mgSs, as well as mgSs of L. iners, were associated with a greater likelihood of bacterial vaginosis diagnosed by Amsel clinical criteria. This L. iners mgSs, among other functional features, encoded enhanced genetic capabilities for epithelial cell attachment that could facilitate cytotoxin-mediated cell lysis. Finally, we report a mgSs and mgCST classifier for which source code is provided and may be adapted for use by the microbiome research community.

conclusionsMgCSTs are a novel and easily implemented approach to reduce the dimension of complex metagenomic datasets while maintaining their functional uniqueness. MgCSTs enable the investigation of multiple strains of the same species and the functional diversity in that species. Future investigations of functional diversity may be key to unraveling the pathways by which the vaginal microbiome modulates the protection of the genital tract. Importantly, our findings support the hypothesis that functional differences between vaginal microbiomes, including those that may look compositionally similar, are critical considerations in vaginal health. Ultimately, mgCSTs may lead to novel hypotheses concerning the role of the vaginal microbiome in promoting health and disease, and identify targets for novel prognostic, diagnostic, and therapeutic strategies to improve women's genital health. Video Abstract.

Indexed as

MicrobiotaVaginosis, BacterialBacteriaFemaleGardnerella vaginalisHumansVaginaBacterial vaginosisGenital healthMetagenomeSequencingVaginal microbiome

Identifiers

PMID38031142
PMCPMC10688475
OpenAlexW4389155349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.